SAT0446 GOUT IN THE US: SIGNIFICANT ASSOCIATIONS WITH CARDIOVASCULAR AND RENAL DISEASE HOSPITALIZATIONS

Background Gout is a disorder of uric acid metabolism and often presents as acute severe joint pain. Previous work from our group suggests that all-cause hospitalizations in patients with gout in the United States (US) have significantly increased by 410% in the last 22 years, almost hundred-fold of the 4.8% increase in US population all-cause hospitalization rate in the same time-period. The current study focused on identifying potential reasons for the excess hospitalizations. Objectives To compare the primary reasons for hospitalizations in patients with gout to those in age-matched patients without gout in the US in 2016. Methods The Nationwide Inpatient Sample (NIS) is a stratified random sample of all US community hospitals. It is the only US national hospital database with information on all patients, regardless of payer, including persons covered by Medicare, Medicaid, private insurance, and the uninsured. We examined all inpatient hospitalizations in the NIS in 2016 among patients 40 years or older with a primary or secondary diagnosis of gout and compared them to total all-cause hospitalizations in patients without a gout diagnosis in the same age group during the same period. Over 69,800 ICD 10 diagnoses codes were collapsed into a smaller number of clinically meaningful categories, consistent with the Centers for Disease Control (CDC) Clinical Classification Software. The top 15 primary causes for hospitalization were evaluated and compared between the two cohorts. Results In 2016, there were 892,379 all-cause hospitalizations in the US in patients with gout with 14,135 (1.6%) of these for a primary diagnosis of gout. The primary diagnoses for 878,244 hospitalizations in patients with gout were compared with those in 21.9 million hospitalizations in the general US population without gout. The most common primary cause of hospitalizations in both cohorts was septicemia (7.8% in gout vs. 7.4% in general population). Significant differences were seen in several other categories. For example, acute renal failure was twice as frequent among gout patients (39,455 hospitalizations, 4.5%) compared to the general population (458,920 hospitalizations, 2.1%) (Relative Risk (RR) 2.11, 95% CI 2.08 – 2.13, p Conclusion Among patients with gout, a far greater proportion of serious hospitalizations are related to renal and cardiovascular complications as compared to age-matched general population. This calls for an increased awareness and management of serious co-morbid conditions in patients with gout. References [1] Singh G, Mithal A, Mithal A. NOT JUST A SWOLLEN BIG TOE: INCREASING ALL-CAUSE HOSPITALIZATIONS IN PATIENTS WITH GOUT IN THE UNITED STATES: 1993–2014: Presented at EULAR Congress2017 Primary reasons for comorbid hospitalizations more common in patients with gout compared with age-matched patients without gout, classified by Centers for Disease Control Clinical Classification Software (CDC CCS). Acknowledgement Supported in part by an unrestricted grant from Horizon Pharma Disclosure of Interests Gurkirpal Singh Shareholder of: Merck, Pfizer, Grant/research support from: Horizon, Acorda, UCB, Consultant for: Horizon, Acorda, Sancilio, Unipharm, Maanek Sehgal: None declared, Alka Mithal: None declared